CMS NCD 240 Updated: What Billing Teams Need to Know About Electrical Nerve Stimulator Coverage
CMS has modified National Coverage Determination (NCD) 240, which governs Medicare coverage for electrical nerve stimulators used in the treatment of chronic intractable pain. This policy update, effective March 12, 2026, affects how billing teams and revenue cycle professionals should approach claims for both implanted peripheral nerve stimulators and central nervous system (CNS) stimulators—including dorsal column and depth brain devices. If your practice or facility bills Medicare for pain management procedures involving these devices, understanding the exact coverage conditions under NCD 240 is essential to avoid denials.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Electrical Nerve Stimulators |
| Policy Code | NCD 240 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | High |
| Specialties Affected | Pain Management, Neurosurgery, Neurology, Anesthesiology, Physical Medicine & Rehabilitation |
| Key Action | Audit your pre-implantation documentation process to confirm all five CMS coverage conditions are met and recorded before submitting claims for CNS stimulator implantation. |
CMS Electrical Nerve Stimulator Coverage: Two Device Categories Under NCD 240
NCD 240 covers two broad categories of electrical nerve stimulators, each with its own coverage pathway and documentation requirements. Billing teams need to understand these categories clearly—because the criteria that unlock reimbursement differ significantly between them.
Implanted Peripheral Nerve Stimulators are classified under the prosthetic device benefit. This classification matters for billing: claims should be submitted under the prosthetic devices benefit category, not as durable medical equipment. The device involves surgically implanted electrodes placed around a peripheral nerve, connected to a subcutaneous receiver unit no deeper than ½ inch below the skin. An external generator transmits stimulation via an antenna placed over the receiver site.
One important nuance: when a peripheral nerve stimulator is used diagnostically—to assess whether a patient is a good candidate for ongoing electrical nerve stimulation therapy—that use is covered as part of a diagnostic service under §160.7.1, not as a prosthesis. This distinction affects which benefit category applies and how the claim should be coded.
CMS CNS Stimulator Coverage Criteria: Five Conditions That Must All Be Met
Central nervous system stimulators—including dorsal column (spinal cord) neurostimulators and depth brain neurostimulators—carry stricter coverage requirements. CMS will not reimburse implantation of these devices unless all five of the following conditions are documented and satisfied:
| # | Covered Indication |
|---|---|
| 1 | Last resort designation: The stimulator is used only as a late resort—if not a last resort—for patients with chronic intractable pain. |
| 2 | Prior treatment failure: Other treatment modalities, including pharmacological, surgical, physical, or psychological therapies, have been tried and failed, or are documented as unsuitable or contraindicated for the specific patient. |
| 3 | Multidisciplinary screening: The patient has undergone thorough screening, evaluation, and diagnosis by a multidisciplinary team before implantation. This screening must explicitly include both psychological and physical evaluation. |
| 4 | Facility and personnel readiness: All necessary facilities, equipment, and qualified professional and support staff for diagnosis, treatment, training, and follow-up care must be available. |
| 5 | Temporary electrode trial: The patient must demonstrate meaningful pain relief with a temporarily implanted electrode before permanent implantation proceeds. |
Every one of these five conditions is required. A claim that demonstrates four out of five still fails CMS's coverage standard. Medicare Administrative Contractors (MACs) reviewing these claims may work with Quality Improvement Organizations (QIOs) to gather the documentation needed to apply these conditions—which means your records need to be airtight before the claim goes out.
Covered Procedure Types Under NCD 240
NCD 240 specifically covers the following implantation approaches for CNS stimulators:
- Dorsal Column (Spinal Cord) Neurostimulation: Both surgical implantation of electrodes within the dura mater (endodural approach) and percutaneous insertion of electrodes in the epidural space are covered.
- Depth Brain Neurostimulation: Stereotactic implantation of electrodes in deep brain structures—including the thalamus and periaqueductal gray matter—is covered when all five conditions above are met.
Both procedures require the full five-condition documentation package. There is no partial coverage pathway for CNS stimulators under this NCD.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The policy document for NCD 240 does not list specific CPT or HCPCS codes. Billing teams should work directly with their MAC to confirm applicable procedure codes for peripheral nerve stimulator implantation, spinal cord stimulator implantation, and depth brain stimulator implantation under this NCD. Cross-reference the Medicare Benefit Policy Manual, Chapter 15, §120, as well as §§160.2 and 30.1 of the NCD manual for additional guidance.
No ICD-10-CM diagnosis codes are enumerated in this policy. Claims should be supported by diagnosis codes that reflect chronic intractable pain and the specific underlying condition, consistent with the five coverage conditions outlined above.
Medicare Benefit Policy Manual Cross-References
CMS cross-references several sections that your compliance and billing teams should review alongside NCD 240:
- Medicare Benefit Policy Manual, Chapter 15, §120 — Covered Medical and Other Health Services
- NCD §160.2 — related coverage guidance
- NCD §30.1 — related coverage guidance
These cross-references are not optional reading. When your MAC reviews a claim under NCD 240, their determination will be informed by these sections as well.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Audit pre-implantation documentation templates before the March 12, 2026 effective date. Confirm your intake and pre-authorization workflows capture all five CNS stimulator coverage conditions explicitly. Each condition should be independently documented in the patient's record—not implied by a general clinical note. |
| 2 | Distinguish diagnostic use from prosthetic use for peripheral nerve stimulators. When a peripheral nerve stimulator is used to evaluate a patient's suitability for ongoing treatment, ensure the claim is submitted under the diagnostic service benefit (§160.7.1), not the prosthetic device benefit. Miscategorizing this can trigger a denial or overpayment audit. |
| 3 | Confirm multidisciplinary screening includes psychological evaluation. CMS is explicit that screening must include psychological assessment, not just physical evaluation. If your facility is referring out for psych evaluation, ensure that documentation is obtained and attached to the record before the permanent implant procedure is scheduled. |
| 4 | Verify temporary electrode trial results are documented. The requirement for demonstrated pain relief with a temporary electrode before permanent implantation is a hard stop—no documentation, no coverage. Create a checklist item in your surgical scheduling workflow that blocks permanent implant scheduling until this record is confirmed. |
| 5 | Contact your MAC proactively if your specialty is frequently billing these procedures. Since MACs may work with QIOs to evaluate claims under NCD 240, getting ahead of potential requests for additional documentation is smart risk management. Ask your MAC representative whether they have a local coverage determination (LCD) that supplements this NCD. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.